Skip to main content

previous disabled Page of 2
and
  1. Article

    Open Access

    CGRP-targeted medication in chronic migraine - systematic review

    Chronic migraine is a highly debilitating condition that is often difficult to manage, particularly in the presence of medication overuse headache. Drugs targeting the calcitonin gene-related peptide (CGRP), o...

    Renato Oliveira, Raquel Gil-Gouveia, Francesca Puledda in The Journal of Headache and Pain (2024)

  2. Article

    Open Access

    Working memory during spontaneous migraine attacks: an fMRI study

    To investigate the neural correlates of working memory during a spontaneous migraine attack compared to the interictal phase, using functional magnetic resonance imaging (fMRI).

    Amparo Ruiz-Tagle, Patrícia Figueiredo, Joana Pinto, Pedro Vilela in Neurological Sciences (2024)

  3. Article

    Open Access

    Impact of truncating diffusion MRI scans on diffusional kurtosis imaging

    Diffusional kurtosis imaging (DKI) extends diffusion tensor imaging (DTI), characterizing non-Gaussian diffusion effects but requires longer acquisition times. To ensure the robustness of DKI parameters, data ...

    Ana R. Fouto, Rafael N. Henriques in Magnetic Resonance Materials in Physics, B… (2024)

  4. Article

    Open Access

    Rethinking headache as a global public health case model for reaching the SDG 3 HEALTH by 2030

    The 2030 Agenda for Sustainable Development sets out, through 17 Sustainable Development Goals (SDGs), a path for the prosperity of people and the planet. SDG 3 in particular aims to ensure healthy lives and p...

    Paolo Martelletti, Matilde Leonardi, Messoud Ashina in The Journal of Headache and Pain (2023)

  5. Article

    Open Access

    European Headache Federation (EHF) critical reappraisal and meta-analysis of oral drugs in migraine prevention – part 3: topiramate

    Topiramate is a repurposed first-line treatment for migraine prophylaxis. The aim of this systematic review and meta-analysis is to critically re-appraise the existing evidence supporting the efficacy and tole...

    Bianca Raffaelli, David García-Azorín in The Journal of Headache and Pain (2023)

  6. Article

    Open Access

    European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention—part 2: flunarizine

    Novel disease-specific and mechanism-based treatments sharing good evidence of efficacy for migraine have been recently marketed. However, reimbursement by insurers depends on treatment failure with classic an...

    Christina I. Deligianni, Simona Sacco, Esme Ekizoglu in The Journal of Headache and Pain (2023)

  7. Article

    Open Access

    The comparative effectiveness of migraine preventive drugs: a systematic review and network meta-analysis

    While there are several trials that support the efficacy of various drugs for migraine prophylaxis against placebo, there is limited evidence addressing the comparative safety and efficacy of these drugs. We c...

    Christian Lampl, Antoinette MaassenVanDenBrink in The Journal of Headache and Pain (2023)

  8. Article

    Open Access

    European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention—part 1: amitriptyline

    The aim of this paper is to critically re-appraise the published trials assessing amitriptyline for migraine prophylaxis.

    Christian Lampl, Jan Versijpt, Faisal Mohammad Amin in The Journal of Headache and Pain (2023)

  9. Article

    Open Access

    European Headache Federation (EHF) consensus on the definition of effective treatment of a migraine attack and of triptan failure

    Triptans are migraine-specific acute treatments. A well-accepted definition of triptan failure is needed in clinical practice and for research. The primary aim of the present Consensus was to provide a definit...

    Simona Sacco, Christian Lampl, Faisal Mohammad Amin in The Journal of Headache and Pain (2022)

  10. Article

    Open Access

    European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention – 2022 update

    A previous European Headache Federation (EHF) guideline addressed the use of monoclonal antibodies targeting the calcitonin gene-related peptide (CGRP) pathway to prevent migraine. Since then, randomized contr...

    Simona Sacco, Faisal Mohammad Amin, Messoud Ashina in The Journal of Headache and Pain (2022)

  11. No Access

    Article

    Persistent monocular visual loss in migraine patients

    The relationship between migraine and vision is complex. Besides migraine aura status and persistent visual aura without infarction, recognized by International Headaches Classification 3, cases of persistent ...

    Sofia Grenho Rodrigues, Raquel Gil Gouveia in Acta Neurologica Belgica (2022)

  12. Article

    Open Access

    TIME, to move forward? comment on “a universal outcome measure for headache treatments, care-delivery systems and economic analysis”

    The paper from Steiner et al. suggests that an outcome measure expressed in time units may be an adequate method to assess the impact of headache disorders, regardless of diagnosis or health care setting, prov...

    Raquel Gil-Gouveia in The Journal of Headache and Pain (2022)

  13. No Access

    Article

    Headache Gauge: a real-life calendar-based tool for headache monitoring

    This study aimed to validate a semi-quantitative composite score tool, “Headache Gauge” (HG), to monitor the treatment effect in primary headaches in everyday clinic practice, adjustable to any chosen timeframe.

    Raquel Gil-Gouveia, Inês Brás Marques, Elsa Paixão Parreira in Neurological Sciences (2021)

  14. Article

    Open Access

    Structured headache services as the solution to the ill-health burden of headache: 1. Rationale and description

    In countries where headache services exist at all, their focus is usually on specialist (tertiary) care. This is clinically and economically inappropriate: most headache disorders can effectively and more effi...

    Timothy J. Steiner, Rigmor Jensen, Zaza Katsarava in The Journal of Headache and Pain (2021)

  15. Article

    Open Access

    Cognitive aging in migraine sufferers is associated with more subjective complaints but similar age-related decline: a 5-year longitudinal study

    The effect of headache on cognitive performance is controversial, due to conflicting results obtained from studies in clinical or population settings. We aimed to understand if migraine and other headaches mod...

    Isabel Pavão Martins, Carolina Maruta in The Journal of Headache and Pain (2020)

  16. No Access

    Article

    Cognition and Cognitive Impairment in Migraine

    Migraine is a complex neurological disorder that affects a significant percentage of the human species, from all geographic areas and cultures. Cognitive symptoms and dysfunctions are interim and disabling com...

    Raquel Gil-Gouveia, Isabel Pavão Martins in Current Pain and Headache Reports (2019)

  17. No Access

    Chapter

    Evaluation: Quality in Headache Services

    This chapter sets out a multidimensional definition of quality in the context of headache care, along with a related set of quality indicators currently undergoing evaluation. Both were developed for the purposes...

    Timothy J. Steiner, Rigmor Jensen, Raquel Gil-Gouveia in Societal Impact of Headache (2019)

  18. Article

    Open Access

    Headache service quality: evaluation of quality indicators in 14 specialist-care centres

    The study was a collaboration between Lifting The Burden (LTB) and the European Headache Federation (EHF). Its aim was to evaluate the implementation of quality indicators for headache care Europe-wide in special...

    Sara Schramm, Derya Uluduz, Raquel Gil Gouveia in The Journal of Headache and Pain (2016)

  19. Article

    Open Access

    Evaluation of headache service quality indicators: pilot implementation in two specialist-care centres

    Evaluating quality of health care is increasingly recognized as an important contributor to the advancement of health-care delivery. We recently developed a set of quality indicators for headache care, intende...

    Zaza Katsarava, Raquel Gil Gouveia, Rigmor Jensen in The Journal of Headache and Pain (2015)

  20. No Access

    Article

    Assessment of cognitive dysfunction during migraine attacks: a systematic review

    Patients consistently report cognitive impairment during migraine attacks, yet the documentation of such dysfunction by neuropsychological evaluation has lacked similar consistency. This incongruence may be du...

    Raquel Gil-Gouveia, António G. Oliveira, Isabel Pavão Martins in Journal of Neurology (2015)

previous disabled Page of 2